Research Consent Models Used in Prospective Studies of Neurologically Deceased Organ Donors: A Systematic Review

Abstract

Research to inform the care of neurologically deceased organ donors is complicated by a lack of standards for research consent. In this systematic review, we aim to describe current practices of soliciting consent for participation in prospective studies of neurologically deceased donors, including the frequency and justification for these various models of consent. Among the 74 studies included, 14 did not report on any regulatory review, and 13 did not report on the study consent procedures. Of the remaining 47 studies, 24 utilized a waiver of research consent. The most common justification for a waiver of research consent related to the fact that neurologically deceased donors are not considered human subjects. In conclusion, among studies of neurologically deceased donors, research consent models vary and are inconsistently reported. Consensus and standardization in the application of research consent models will help to advance this emerging field of research.

Keywords

organ donation donor intervention research consent transplantation

Get full access to this article

View all access options for this article.

References

Abt

P. L.

Marsh

C. L.

Dunn

T. B.

Hewitt

W. R.

Rodrigue

J. R.

Ham

J. M.

Feng

(2013). Challenges to research and innovation to optimize deceased donor organ quality and quantity. American Journal of Transplantation, 13(6), 1400–1404. https://doi.org/10.1111/ajt.12243

Bloom

M. B.

Raza

Bhakta

Ewing

Patel

Ley

E. J.

. . . Malinoski

(2015). Impact of deceased organ donor demographics and critical care end points on liver transplantation and graft survival rates. Journal of the American College of Surgeons, 220(1), 38–47. https://doi.org/10.1016/j.jamcollsurg.2014.09.020

Canadian Institute for Health Information. (2018, December 18). Organ replacement in Canada: CORR annual statistics, 2018. https://www.cihi.ca/en/organ-replacement-in-canada-corr-annual-statistics-2018

Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, and Social Sciences and Humanities Research Council of Canada. (2014, December). Tri-council policy statement: Ethical conduct for research involving humans. http://www.pre.ethics.gc.ca/eng/documents/tcps2-2018-en-interactive-final.pdf

Chassé

Glen

Doyle

M. A.

McIntyre

English

S. W.

Knoll

. . . Fergusson

D. A.

(2013). Ancillary testing for diagnosis of brain death: A protocol for a systematic review and meta-analysis. Systematic Reviews, 2, 100. https://doi.org/10.1186/2046-4053-2-100

Chen

Selamet Tierney

E. S.

Khush

K. K.

Nguyen

Goldstein

B. A.

May

L. J.

. . . Rosenthal

D. N

. (2015). Reliability of echocardiographic measurements of left ventricular systolic function in potential pediatric heart transplant donors. Journal of Heart and Lung Transplantation, 34(1), 100–106. https://doi.org/10.1016/j.healun.2014.08.019

Cinotti

Roquilly

Mahé

P. J.

Feuillet

Yehia

Belliard

. . . Asehnoune

(2014). Pulse pressure variations to guide fluid therapy in donors: A multicentric echocardiographic observational study. Journal of Critical Care, 29(4), 489–494. https://doi.org/10.1016/j.jcrc.2014.03.027

de la Cruz

J. S.

Sally

M. B.

Zatarain

J. R.

Crutchfield

Ramsey

Nielsen

. . . Malinoski

D. J.

(2015). The impact of blood transfusions in deceased organ donors on the outcomes of 1,884 renal grafts from United Network for Organ Sharing Region 5. Journal of Trauma and Acute Care Surgery, 79(4 Suppl. 2), S164–S170. https://doi.org/10.1097/TA.0000000000000670

Dikdan

G. S.

Mora-Esteves

Koneru

(2012). Review of randomized clinical trials of donor management and organ preservation in deceased donors: Opportunities and issues. Transplantation, 94(5), 425–441. https://doi.org/10.1097/TP.0b013e3182547537

10.

Eyraud

Ben Ayed

Tanguy

M. L.

Vézinet

Siksik

J. M.

Bernard

. . . Hannoun

(2008). Procalcitonin in liver transplantation: Are high levels due to donors or recipients? Critical Care, 12(4), Article R85. https://doi.org/10.1186/cc6942

11.

Feng

(2010). Donor intervention and organ preservation: Where is the science and what are the obstacles? American Journal of Transplantation, 10(5), 1155–1162. https://doi.org/10.1111/j.1600-6143.2010.03100.x

12.

Glazier

A. K.

Heffernan

K. G.

Rodrigue

J. R.

(2015). A framework for conducting deceased donor research in the United States. Transplantation, 99(11), 2252–2257. https://doi.org/10.1097/tp.0000000000000841

13.

Health Resources & Services Administration. (2019, January 16). Organ donation statistics. U.S. Government information on organ donation and transplantation. https://www.organdonor.gov/statistics-stories/statistics.html#transplants

14.

Levvey

B. J.

Westall

G. P.

Kotsimbos

Williams

T. J.

Snell

G. I.

(2008). Definitions of warm ischemic time when using controlled donation after cardiac death lung donors. Transplantation, 86(12), 1702–1706. https://doi.org/10.1097/TP.0b013e3181901f24

15.

Malinoski

D. J.

Patel

M. S.

Ahmed

Daly

M. C.

Mooney

Graybill

C. O.

. . . Salim

(2013). The impact of meeting donor management goals on the development of delayed graft function in kidney transplant recipients. American Journal of Transplantation, 13(4), 993–1000. https://doi.org/10.1111/ajt.12090

16.

Mascia

Pasero

Slutsky

A. S.

Arguis

M. J.

Berardino

Grasso

. . . Ranieri

V. M.

(2010). Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: A randomized controlled trial. Journal of the American Medical Association, 304(23), 2620–2627. https://doi.org/10.1001/jama.2010.1796

17.

Meyfroidt

Gunst

Martin-Loeches

Smith

Robba

Taccone

F. S.

Citerio

(2019). Management of the brain-dead donor in the ICU: General and specific therapy to improve transplantable organ quality. Intensive Care Medicine, 45(3), 343–353. https://doi.org/10.1007/s00134-019-05551-y

18.

Mone

Heldens

Niemann

C. U.

(2013). Deceased organ donor research: The last research frontier? Liver Transplantation, 19(2), 118–121. https://doi.org/10.1002/lt.23579

19.

Muller

Nicolas-Robin

Bastide

Martinez

Louart

Colavolpe

J. C.

. . . Riou

(2015). Assessment of neutrophil gelatinase-associated lipocalin in the brain-dead organ donor to predict immediate graft function in kidney recipients: A prospective, multicenter study. Anesthesiology, 122(1), 96–105. https://doi.org/10.1097/ALN.0000000000000497

20.

National Academies of Sciences, Engineering, and Medicine. (2017). Opportunities for organ donor intervention research: Saving lives by improving the quality and quantity of organs for transplantation ( J. F.

Childress

Domnitz

C. T.

Liverman

Domnitz

, Eds.). The National Academies Press. https://doi.org/10.17226/24884.

21.

National Conference of Commissioners on Uniform State Laws. (2006). Revised Uniform Anatomical Gift Act. http://www.anatomicalgiftact.org/DesktopDefault.aspx?tabindex=0&tabid=1

22.

NHS Blood and Transplant. (2019). Organ donation and transplantation. https://www.nhsbt.nhs.uk/what-we-do/transplantation-services/organ-donation-and-transplantation/

23.

Nicolas-Robin

Salvi

Medimagh

Amour

Le Manach

Coriat

. . . Langeron

(2007). Combined measurements of N-terminal pro-brain natriuretic peptide and cardiac troponins in potential organ donors. Intensive Care Medicine, 33(6), 986–992. https://doi.org/10.1007/s00134-007-0601-7

24.

Niemann

C. U.

Feiner

Swain

Bunting

Friedman

Crutchfield

. . . Malinoski

(2015). Therapeutic hypothermia in deceased organ donors and kidney-graft function. New England Journal of Medicine, 373(5), 405–414. https://doi.org/10.1056/NEJMoa1501969

25.

Office of Research Oversight, Veterans Affairs. (2016, April 20). Letter to Public Citizen Health Research Group. https://www.citizen.org/wp-content/uploads/migration/2315.pdf

26.

Orban

J.-C.

Fontaine

Cassuto

Baumstarck

Leone

Constantin

J.-M.

Ichai

(2018). Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): Study protocol for a randomized controlled trial. Trials, 19(1), 231. https://doi.org/https://doi.org/10.1186/s13063-018-2597-4

27.

Pinsard

Ragot

Mertes

P. M.

Bleichner

J. P.

Zitouni

Cook

. . . Pichon

(2014). Interest of low-dose hydrocortisone therapy during brain-dead organ donor resuscitation: The CORTICOME study. Critical Care, 18(4), Article R158. https://doi.org/10.1186/cc13997

28.

Protection of Human Subjects, 21 C.F.R, § 50.3(g). (2018).

29.

Rodrigue

J. R.

Feng

Johansson

A. C.

Glazier

A. K.

Abt

P. L.

(2016). Deceased donor intervention research: A survey of transplant surgeons, organ procurement professionals, and institutional review board members. American Journal of Transplantation, 16(1), 278–286. https://doi.org/10.1111/ajt.13482

30.

Rudge

Matesanz

Delmonico

F. L.

Chapman

(2012). International practices of organ donation. British Journal of Anaesthesia, 108(Suppl. 1), i48–i55. https://doi.org/10.1093/bja/aer399

31.

Sally

M. B.

Ewing

Crutchfield

Patel

M. S.

Raza

De La Cruz

. . . Malinoski

D. J.

(2014). Determining optimal threshold for glucose control in organ donors after neurologic determination of death: A United Network for Organ Sharing Region 5 Donor Management Goals Workgroup prospective analysis. Journal of Trauma and Acute Care Surgery, 76(1), 62–68; discussion 68–69. https://doi.org/10.1097/TA.0b013e3182ab0d9b

32.

Shah

V. R.

(2008). Aggressive management of multiorgan donor. Transplantation Proceedings, 40(4), 1087–1090. https://doi.org/10.1016/j.transproceed.2008.03.029

33.

Suntharalingam

Sharples

Dudley

Bradley

J. A.

Watson

C. J.

(2009). Time to cardiac death after withdrawal of life-sustaining treatment in potential organ donors. American Journal of Transplantation, 9(9), 2157–2165. https://doi.org/10.1111/j.1600-6143.2009.02758.x

34.

van Beinum

Hornby

Dhanani

Ward

Chambers-Evans

Menon

. (2017). Feasibility of conducting prospective observational research on critically ill, dying patients in the intensive care unit. Journal of Medical Ethics, 43(1), 47–51. https://doi.org/10.1136/medethics-2016-103683

35.

Ware

L. B.

Koyama

Billheimer

Landeck

Johnson

Brady

. . . Matthay

M. A.

(2011). Advancing donor management research: Design and implementation of a large, randomized, placebo-controlled trial. Annals of Intensive Care, 1(1), 20. https://doi.org/10.1186/2110-5820-1-20

36.

Wind

Snoeijs

M. G.

Brugman

C. A.

Vervelde

Zwaveling

van Mook

W. N.

van Heurn

E. L.

(2012). Prediction of time of death after withdrawal of life-sustaining treatment in potential donors after cardiac death. Critical Care Medicine, 40(3), 766–769. https://doi.org/10.1097/CCM.0b013e318232e2e7

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.26 MB